Posted by Michael Wonder on 27 Nov 2023
FDA approves nirogacestat for desmoid tumours
27 November 2023 - Today, the FDA approved nirogacestat (Ogsiveo, SpringWorks Therapeutics) for adult patients with progressing desmoid tumours who require systemic treatment.
This is the first approved treatment for desmoid tumours.
